SMA News Forums Forums Awareness and Advocacy Raising Awareness of SMA The SMA News Today Podcast Episode 38: Treatment Updates & the 2019 Cure SMA Conference

  • kevin-schaefer

    July 18, 2019 at 1:47 pm

    Quick correction: I said in the episode that Reldesemtiv was developed by Genentech. It was developed by Cytokinetics, and Risdiplam was developed by Genentech. My bad! Journalists still make mistakes, but I just wanted to correct myself. Thanks!

Log in to reply.